Authors

• Vasileios Kouranos (ORCID: https://orcid.org/0000-0002-2723-0928)
• Richard Hewitt (ORCID: https://orcid.org/0000-0003-4294-0052)
• G. Castelli (ORCID: https://orcid.org/0000-0002-5925-4035)
• Arthihai Srirangan
• Piersante Sestini (ORCID: https://orcid.org/0000-0002-8195-0811)
• Elisabetta Renzoni (ORCID: https://orcid.org/0000-0002-1118-797X)
• G Korff
• Punchalee Kaenmuang (ORCID: https://orcid.org/0000-0001-7877-0468)
• Luís Ferreira (ORCID: https://orcid.org/0000-0001-9840-5767)
• Maria Kokosi (ORCID: https://orcid.org/0000-0002-6427-1681)
• Simon Bax
• Alastair Duncan (ORCID: https://orcid.org/0000-0002-6284-8192)
• Matteo Morviducci
• Peter Myles George (ORCID: https://orcid.org/0000-0003-1316-4891)
• Carmel Stock (ORCID: https://orcid.org/0000-0003-4090-8761)
• Felix Chua (ORCID: https://orcid.org/0000-0001-7845-0173)
• Philip L. Molyneaux (ORCID: https://orcid.org/0000-0003-1301-8800)
• Rasleen Kahai
• Flavio Marco Mirabelli (ORCID: https://orcid.org/0009-0001-0649-8765)
• Richard Gisli Jenkins
• Fiammetta Danzo (ORCID: https://orcid.org/0000-0001-8833-3675)
• Athol U. Wells (ORCID: https://orcid.org/0000-0003-2108-6248)
• Steve Jones
• Winston Banya
• Cara Roberts

Institutions

• University of Siena (IT)
• Guy's and St Thomas' NHS Foundation Trust (GB)
• Royal Brompton Hospital (GB)
• Lung Institute (US)
• European Steel Association (BE)

Publication Details

Journal

CHEST Journal

Published

2025-09-26

DOI

https://doi.org/10.1016/j.chest.2025.09.021

Primary Topic

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Type

article

Field-Weighted Citation Impact

0.00

Funders

• AstraZeneca
• F. Hoffmann-La Roche
• United Therapeutics Corporation
• European Respiratory Society
• Asthma and Lung UK
• King's Health Partners